The Global Aortic Aneurysm Stent Grafts Market is expected to reach US$ 3.8 Bn in 2031 with a growth rate of 7.8% during the forecast period of 2024-2031. The aortic aneurysm stent grafts market falls under the medical devices industry and focuses on the development and commercialization of minimally invasive devices used to treat aortic aneurysms, which are bulges or swellings in the aorta, the main blood vessel carrying blood from the heart to the rest of the body.

Aortic aneurysm stent grafts are tubular devices made of fabric and metal that are inserted through a small incision in the groin or arm and guided to the site of the aneurysm, where they are deployed to reinforce the weakened aortic wall and prevent rupture. This procedure, known as endovascular aneurysm repair (EVAR), is less invasive than open surgical repair and offers faster recovery times and reduced complications, driving the demand for these devices.

The growth of the aortic aneurysm stent grafts market is fueled by several factors, including the increasing prevalence of aortic aneurysms due to an aging population and lifestyle factors such as smoking and obesity. Additionally, the growing preference for minimally invasive procedures, technological advancements in stent graft design and delivery systems, and rising healthcare expenditure in emerging markets are contributing to the market's expansion.

The aortic aneurysm stent grafts market is characterized by a favorable growth dynamic, driven by increasing market opportunities and the continuous development of innovative technologies. The market dynamics are shaped by factors such as the rising demand for minimally invasive treatments, advancements in imaging and guidance systems, and the emergence of novel approaches like patient-specific and biodegradable stent grafts. Furthermore, the market opportunity assessment highlights the potential for growth in emerging markets, where improving healthcare infrastructure and increasing awareness of aortic aneurysms are expected to drive demand for advanced treatment options like stent grafts.

The aortic aneurysm stent grafts market falls under the medical devices industry. An aortic aneurysm is a bulge or swelling in the aorta, the main blood vessel that carries blood from the heart to the rest of the body. It can occur in the abdominal aorta (abdominal aortic aneurysm) or the thoracic aorta (thoracic aortic aneurysm). Aortic aneurysms are often caused by weakening of the aortic wall due to factors such as age, smoking, high blood pressure, and genetic conditions. If left untreated, an aortic aneurysm can rupture, leading to life-threatening internal bleeding. Treatment options include surgical repair or minimally invasive endovascular aneurysm repair (EVAR), which involves the placement of a stent graft to reinforce the weakened aortic wall.

Key Report Insights:

• Major market driver: Increasing prevalence of aortic aneurysms due to an aging population and lifestyle factors such as smoking and obesity. According to the Centers for Disease Control and Prevention (CDC), aortic aneurysms were the primary cause of 9,923 deaths in the United States in 2019.
• Companies are investing in research and development to improve stent graft technology, such as developing low-profile delivery systems, enhancing graft conformability, and incorporating advanced imaging techniques for better procedural guidance. Examples of pipeline products include Endologix's Ovation Alto Abdominal Stent Graft System and Medtronic's Valiant Navion Thoracic Stent Graft System.
• Advancements in diagnostics, such as the use of computed tomography angiography (CTA) and magnetic resonance angiography (MRA), have improved the early detection and monitoring of aortic aneurysms, leading to increased demand for stent grafts.
• Technological advancements, such as the development of fenestrated and branched stent grafts, have expanded the treatment options for complex aortic aneurysms, potentially driving market growth.

Drivers:

• Increasing Prevalence of Aortic Aneurysms: The rising prevalence of aortic aneurysms, particularly among the elderly population, is a significant driver for the aortic aneurysm stent grafts market. According to the Centers for Disease Control and Prevention (CDC), aortic aneurysms were the primary cause of 9,923 deaths in the United States in 2019, highlighting the need for effective treatment options.
• Technological Advancements in Stent Graft Design: Continuous technological advancements in stent graft design and delivery systems have significantly contributed to the growth of the market. Improved graft conformability, lower profile delivery systems, and enhanced imaging guidance have made the procedure more effective and accessible for a wider range of patient anatomies.

Trends:

• Shift towards Low-Profile Delivery Systems: One of the key trends in the market is the shift towards low-profile delivery systems, enabling smaller incisions and easier access to challenging anatomies.
• Focus on Improving Graft Conformability: Another notable trend is the focus on improving graft conformability to better adapt to individual patient anatomies and reduce complications.

Market Opportunity:

The integration of advanced imaging and guidance systems presents an opportunity for improving the accuracy and safety of endovascular aneurysm repair procedures.

Key Regional Insights:

• North America, accounting for over 38.2% of the market share in 2024. Prominent companies in the region include Medtronic, Endologix, and W. L. Gore & Associates. The growth of the market in North America is attributed to the advanced healthcare infrastructure, favorable reimbursement policies, and the presence of major market players.
• Europe, accounting for over 30.1% of the market share in 2024. Prominent companies in the region include Terumo Corporation, Cook Medical, and Jotec GmbH. The growth of the market in Europe is driven by the aging population, increasing awareness of aortic aneurysms, and the adoption of minimally invasive procedures.
• Prominent companies present in the market: Medtronic, Endologix, W. L. Gore & Associates, Cook Medical, Terumo Corporation, Cardinal Health, MicroPort Scientific Corporation, Lombard Medical, Jotec GmbH, and TriVascular Technologies, Inc.

Market Segmentation:

• By Product Type
  • Abdominal Aortic Aneurysm Stent Grafts
  • Thoracic Aortic Aneurysm Stent Grafts
  • Fenestrated Stent Grafts
  • Branched Stent Grafts
  • Others (Aorto-Uni-Iliac Stent Grafts, Aorto-Bi-Iliac Stent Grafts)
• By Aneurysm Type
  • Abdominal Aortic Aneurysm
  • Thoracic Aortic Aneurysm
  • Others (Thoracoabdominal Aortic Aneurysm, Aortic Arch Aneurysm)
• By End-User
  • Hospitals
  • Ambulatory Surgical Centers
  • Specialty Clinics
  • Others (Catheterization Laboratories, Research Institutes)
• By Anatomy
  • Infrarenal Aneurysms
  • Pararenal Aneurysms
  • Suprarenal Aneurysms
  • Others (Thoracoabdominal Aneurysms, Aortic Arch Aneurysms)
• By Material
  • Polyester
  • Polytetrafluoroethylene (PTFE)
  • Nitinol
  • Others (Dacron, ePTFE)
• By Delivery System
  • Bifurcated Delivery Systems
  • Aorto-Uni-Iliac Delivery Systems
  • Aorto-Bi-Iliac Delivery Systems
  • Others (Fenestrated Delivery Systems, Branched Delivery Systems)
• C. By Regions
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

Definition:

“The Aortic Aneurysm Stent Grafts Market refers to the industry that manufactures and supplies medical devices called stent grafts, which are used in the minimally invasive treatment of aortic aneurysms. An aortic aneurysm is a bulge or swelling in the aorta, the main blood vessel that carries blood from the heart to the rest of the body. Stent grafts are tube-shaped devices made of fabric and metal that are inserted through a small incision in the groin or arm and guided to the site of the aneurysm, where they are deployed to reinforce the weakened aortic wall and prevent rupture.”